However, although concurrent JAK2 and IDH/TET2 mutations have been reported with high frequency in post-MPN AML (9), the lack of overt acute transformation in mice with these concurrent mutations suggests that there are additional genetic and epigenetic events that are required to induce the transformation from MPN to AML. The gene discussed is TET2; the disease is myeloproliferative neoplasm.